日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systems

对慢性抗抑郁治疗反应分子通路活性的阐明表明,谷氨酸能系统和泛素-蛋白酶体系统发挥着重要作用。

Park, D I; Dournes, C; Sillaber, I; Ising, M; Asara, J M; Webhofer, C; Filiou, M D; Müller, M B; Turck, C W

Convergent animal and human evidence suggests the activin/inhibin pathway to be involved in antidepressant response.

动物和人类的趋同证据表明,激活素/抑制素通路参与了抗抑郁反应

Ganea K, Menke A, Schmidt M V, Lucae S, Rammes G, Liebl C, Harbich D, Sterlemann V, Storch C, Uhr M, Holsboer F, Binder E B, Sillaber I, Müller M B

Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation

抗抑郁药物作用的代谢物分析揭示了除单胺类神经递质水平升高之外的新型药物靶点。

Webhofer, C; Gormanns, P; Tolstikov, V; Zieglgänsberger, W; Sillaber, I; Holsboer, F; Turck, C W